HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chrysoula Belessi Selected Research

Cyclophosphamide (Cytoxan)

2/2016Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chrysoula Belessi Research Topics

Disease

28B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2024 - 01/2005
6Lymphoma (Lymphomas)
01/2019 - 07/2004
3Neoplasms (Cancer)
06/2015 - 07/2004
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2013 - 05/2013
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2003 - 03/2003
1Multiple Myeloma
01/2023
1Leukemia
11/2018
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2015
1Disease Progression
11/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2008

Drug/Important Bio-Agent (IBA)

21Immunoglobulins (Immunoglobulin)IBA
02/2024 - 07/2004
11AntigensIBA
01/2019 - 07/2004
3Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2019 - 01/2007
3Toll-Like Receptors (Toll-Like Receptor)IBA
11/2015 - 11/2011
2Immunoglobulin G (IgG)IBA
01/2023 - 01/2014
2Proteins (Proteins, Gene)FDA Link
11/2018 - 05/2013
2Messenger RNA (mRNA)IBA
06/2015 - 12/2003
2Cytidine DeaminaseIBA
06/2015 - 04/2010
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2009 - 11/2005
2Transferrin Receptors (Transferrin Receptor)IBA
09/2008 - 12/2003
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2008 - 03/2003
2IgKIBA
11/2005 - 01/2005
1Immunoglobulin A (IgA)IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2022
1Rituximab (Mabthera)FDA Link
02/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2016
1fludarabineIBA
02/2016
1Immunoglobulin D (IgD)IBA
01/2014
1Immunoglobulin M (IgM)IBA
01/2014
1Enhancer of Zeste Homolog 2 ProteinIBA
05/2013
1mouse MIRN29 microRNAIBA
05/2013
1MicroRNAs (MicroRNA)IBA
05/2013
1Terminator Codon (Termination Codon)IBA
10/2012
1Interleukin-6 (Interleukin 6)IBA
11/2011
1Transferrin (beta 2 Transferrin)IBA
02/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2005
1Complementary DNA (cDNA)IBA
01/2005
1Antigen Receptors (Antigen Receptor)IBA
03/2003
1Recombinases (Recombinase)IBA
03/2003

Therapy/Procedure

2Therapeutics
01/2018 - 05/2012
1Splenectomy
03/2007